GNH USA

Europe — EMA

Noradrenaline (Tartrate) (Sans Sulfites) Aguettant (Noradrenaline Tartrate)

GNH USA supplies Noradrenaline (Tartrate) (Sans Sulfites) Aguettant (Norepinephrine tartrate), a vasopressor for hypotension, septic shock, and cardiac

Noradrenaline Tartrate

Request sourcing

1
Pack/s

What is Noradrenaline Tartrate?

Norepinephrine tartrate, the active ingredient in Noradrenaline (Tartrate) (Sans Sulfites) Aguettant, is a sympathomimetic presented as a solution for injection for intravenous use. It treats hypotension, septic shock and cardiac arrest in acute care settings.

GNH USA supplies Noradrenaline (Tartrate) (Sans Sulfites) Aguettant as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

What is Noradrenaline Tartrate used for?

Noradrenaline (Tartrate) is a vasopressor that acts on the sympathetic nervous system to raise blood pressure.

- Hypotension: restores arterial pressure in patients with acute low blood pressure. - Septic shock: supports circulatory function by increasing systemic vascular resistance. - Cardiac arrest: provides temporary hemodynamic support during resuscitation efforts.

What are the side effects of Noradrenaline Tartrate?

Noradrenaline (Tartrate) may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Tachycardia: increased heart rate. - Hypertension: elevated blood pressure. - Headache: mild to moderate intensity. - Peripheral ischemia: reduced blood flow to extremities.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances. - Tissue necrosis: extravasation leading to local tissue damage. - Severe hypertension crisis: dangerously high blood pressure.

What precautions apply to Noradrenaline Tartrate?

When using Noradrenaline (Tartrate), clinicians should observe several safety measures.

- Dose titration: adjust infusion rate based on continuous blood pressure monitoring. - Cardiac monitoring: observe for arrhythmias and ischemia during therapy. - Fluid status: ensure adequate intravascular volume before initiating infusion. - Concomitant vasopressors: avoid simultaneous use with other potent vasoconstrictors unless clinically justified. - Patient population: use with caution in patients with pre‑existing coronary artery disease. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Noradrenaline Tartrate interact with?

Noradrenaline (Tartrate) can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - MAO inhibitors: may cause hypertensive crisis. - Tricyclic antidepressants: increase risk of severe hypertension. - Beta‑blockers: can blunt the expected increase in heart rate.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance vasoconstrictive effect. - Diuretics: can exacerbate hypovolemia, affecting response. - Inhaled anesthetics: may potentiate cardiovascular instability.

Frequently asked questions

What is Noradrenaline (Tartrate) (Sans Sulfites) Aguettant used for?+
Noradrenaline (Tartrate) (Sans Sulfites) Aguettant is a prescription vasopressor indicated for the acute management of severe hypotension, septic shock, and as a temporary circulatory support during cardiac arrest. It is administered in intensive care or emergency settings to rapidly raise blood pressure and improve organ perfusion.
How does norepinephrine tartrate work?+
Norepinephrine tartrate directly stimulates alpha‑1 adrenergic receptors on vascular smooth muscle, causing potent vasoconstriction and an increase in systemic vascular resistance. It also activates beta‑1 receptors in the heart, modestly enhancing contractility and heart rate, together resulting in elevated mean arterial pressure.
What determines the usual dose of this medication?+
The dose of Noradrenaline (Tartrate) is individualized and set by the prescribing clinician. It is typically titrated by continuous intravenous infusion, guided by real‑time blood pressure measurements and the patient’s hemodynamic response, rather than a fixed standard regimen.
Is it safe to use during pregnancy or breastfeeding?+
Safety data for norepinephrine tartrate in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, and it should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant.
How do I order Noradrenaline (Tartrate) (Sans Sulfites) Aguettant from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.
How does this product compare with other vasopressors such as phenylephrine?+
Norepinephrine tartrate has both alpha‑1 and beta‑1 activity, offering vasoconstriction plus modest cardiac stimulation, whereas phenylephrine is a pure alpha‑1 agonist and may reduce heart rate. Clinicians often prefer norepinephrine for septic shock because its combined actions better maintain cardiac output while raising blood pressure.
What are the recommended storage conditions for this injection solution?+
The solution should be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the vial, and avoid prolonged exposure to temperatures above the recommended range to preserve stability.
How is the medication administered to patients?+
Noradrenaline (Tartrate) is supplied as a sterile solution for intravenous infusion. It is typically administered through a calibrated infusion pump, allowing precise titration of the infusion rate based on continuous hemodynamic monitoring.
What are the most serious risks to watch for?+
Serious risks include cardiac arrhythmias, severe hypertension, and tissue necrosis if the drug extravasates from the vein. Continuous cardiovascular monitoring and careful intravenous access management are essential to detect and mitigate these complications promptly.
Who should not use this medication?+
Patients with known hypersensitivity to norepinephrine or any component of the formulation should not receive the product. Caution is also advised in individuals with severe peripheral vascular disease, uncontrolled hypertension, or those receiving other potent vasoconstrictors without clear clinical justification.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Noradrenaline Tartrate
Route
Intravenous Use
Manufacturer
Laboratoire Aguettant
Origin
EU

Related products

Cronomir

Cronomir

Noradrenaline Tartrate

Laboratoire Aguettant
EU
L-Noradrenalina Braun

L-Noradrenalina Braun

Noradrenaline Tartrate

B. Braun Medical Lda.
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU